Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 18856.90 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 30-06-2021, the company reported a Standalone Total Income of Rs 806.20 Crore, up 7.29 % from last quarter Total Income of Rs 751.40 Crore and up 8.99 % from last year same quarter Total Income of Rs 739.70 Crore. Company reported net profit after tax of Rs 178.30 Crore in latest quarter.
Investment Rationale
- Future launches from its global staple along with brand extensions
- Access to innovative molecules from parent like recently launched antidiabetic drug Toujeo
- Strong balance sheet, good dividend payout track record and comfort on corporate governance
- Consistent performer despite four core brands are under price control
Promoter/FII Holdings
Promoters held 60.4 per cent stake in the company as of Dec 30, 2020, while FIIs held 11.5 per cent, DIIs 17.5 per cent and public and other 10.6 per cent.
(Disclaimer: Views and recommendations given in this section are the analysts’ own and do not represent those of ETMarkets.com. Please consult your financial adviser before taking any position in the stock/s mentioned.
